{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:55Z","timestamp":1791644455379,"version":"4.3.4"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is an increasing utilization of ultrahypofractionation radiotherapy plans in whole breast radiotherapy. This study presents a comparative analysis of ultrahypofractionation using volumetric modulated arc therapy (VMAT) and intensity modulated proton therapy (IMPT) in treatment planning for patients undergoing breast conserving surgery (BCS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>CT datasets of twenty patients undergoing BCS, with ten on the left side and ten on the right side, were retrospectively replanned using both VMAT and IMPT techniques. The study included four scenarios: left\/right breast only and left\/right breast with regional nodes. A total dose of 26 Gy(RBE) was prescribed in 5 fractions. The CTV (clinical target volume) was optimized for IMPT, incorporating a 3 mm setup uncertainty and a 3.5% range uncertainty. The planning target volume (PTV) was used for VMAT optimization and evaluation for both techniques. Dose to the target volume and organs at risk (OARs) between IMPT and VMAT was analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The PTV-D95, along with the V10 and V20 of the ipsilateral lungs, was comparable between VMAT and IMPT plans. The ipsilateral lung Dmean and V5 were significantly lower for the IMPT methods for breast-only radiotherapy and for the right breast with regional nodes. IMPT plans showed significantly reduced Dmean, V5, and V10 doses to the contralateral lung, as well as Dmean and V5 doses to the heart in all subgroups. The Dmean of the heart was less than 1 Gy for the left-sided and less than 0.5 Gy for the right-sided subgroup in IMPT plans. However, the IMPT plans showed a significantly higher Dmax for the skin surface in all subgroups, as well as for the esophagus in the left breast with regional nodes subgroup.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IMPT plans significantly reduced radiation exposure to most surrounding OARs compared to VMAT. Clinical outcomes are needed to confirm the potential for reduced late toxicities. However, this benefit was accompanied by an increased skin surface dose and, in specific cases, a higher esophageal dose.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0344699","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:36:49Z","timestamp":1773250609000},"page":"e0344699","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dosimetric comparison study of ultrahypofractionated photon versus proton treatment plans in post breast-conserving surgery breast cancer"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-8661","authenticated-orcid":true,"given":"Kitwadee","family":"Saksornchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanawat","family":"Tawonwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puntiwa","family":"Oonsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mananchaya","family":"Vimolnoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanaporn","family":"Sarsitthithum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chawalit","family":"Lertbutsayanukul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3744-0830","authenticated-orcid":true,"given":"Chonnipa","family":"Nantavithya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"16","key":"pone.0344699.ref001","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"B Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"pone.0344699.ref002","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Breast Cancer: National Comprehensive Cancer Network. 2022 [cited 2022 Sep 7]. Version 4.2022. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"issue":"9804","key":"pone.0344699.ref003","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"(EBCTCG) Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"pone.0344699.ref004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"TJ Whelan","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0344699.ref005","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"JS Haviland","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"pone.0344699.ref006","first-page":"229","article-title":"Skin toxicity and cosmesis after hypofractionated whole breast irradiation for early breast cancer","volume":"95","author":"K Saksornchai","year":"2012","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"pone.0344699.ref007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3857\/roj.2021.00927","article-title":"Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer","volume":"40","author":"C Lertbutsayanukul","year":"2022","journal-title":"Radiat Oncol J"},{"issue":"10237","key":"pone.0344699.ref008","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"A Murray Brunt","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"pone.0344699.ref009","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3857\/roj.2020.00619","article-title":"Dosimetric comparative study of 3DCRT, IMRT, VMAT, Ecomp, and Hybrid techniques for breast radiation therapy","volume":"38","author":"SN Chen","year":"2020","journal-title":"Radiat Oncol J"},{"issue":"4","key":"pone.0344699.ref010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1017\/S1460396917000243","article-title":"Dosimetric study of three-dimensional conformal radiotherapy, electronic compensator technique, intensity-modulated radiation therapy and volumetric-modulated arc therapy in whole breast irradiation","volume":"16","author":"C Nantavithya","year":"2017","journal-title":"J Radiother Pract"},{"issue":"1","key":"pone.0344699.ref011","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ijrobp.2015.09.018","article-title":"Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons","volume":"95","author":"JA Bradley","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"pone.0344699.ref012","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/acm2.12497","article-title":"A comprehensive dosimetric study of Monte Carlo and pencil-beam algorithms on intensity-modulated proton therapy for breast cancer","volume":"20","author":"X Liang","year":"2019","journal-title":"J Appl Clin Med Phys"},{"issue":"3","key":"pone.0344699.ref013","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ijrobp.2013.01.038","article-title":"Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial","volume":"86","author":"SM MacDonald","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"pone.0344699.ref014","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijrobp.2015.01.005","article-title":"Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer","volume":"92","author":"JJ Cuaron","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"pone.0344699.ref015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13014-022-01992-w","article-title":"Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy","volume":"17","author":"P Oonsiri","year":"2022","journal-title":"Radiat Oncol"},{"key":"pone.0344699.ref016","article-title":"Breast Contouring","author":"SM MacDonald","year":"2016","journal-title":"RADCOMP Consortium"},{"issue":"3","key":"pone.0344699.ref017","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"S-L Wang","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"pone.0344699.ref018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13014-019-1378-x","article-title":"Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity","volume":"14","author":"I Chitapanarux","year":"2019","journal-title":"Radiat Oncol"},{"issue":"3","key":"pone.0344699.ref019","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijrobp.2016.11.010","article-title":"Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer","volume":"97","author":"S Bellefqih","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"pone.0344699.ref020","doi-asserted-by":"crossref","first-page":"103090","DOI":"10.1016\/j.critrevonc.2020.103090","article-title":"The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review","volume":"156","author":"GN Marta","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"pone.0344699.ref021","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"CM van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"issue":"2","key":"pone.0344699.ref022","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.radonc.2011.01.010","article-title":"Is \u03b1\/\u03b2 for breast cancer really low?","volume":"100","author":"XS Qi","year":"2011","journal-title":"Radiother Oncol"},{"issue":"1","key":"pone.0344699.ref023","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"I Meattini","year":"2022","journal-title":"Lancet Oncol"},{"issue":"2","key":"pone.0344699.ref024","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrc2587","article-title":"Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype","volume":"9","author":"GC Barnett","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"pone.0344699.ref025","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1080\/0284186X.2021.1907860","article-title":"Cardiac substructure exposure in breast radiotherapy: a comparison between intensity modulated proton therapy and volumetric modulated arc therapy","volume":"60","author":"P Loap","year":"2021","journal-title":"Acta Oncol"},{"key":"pone.0344699.ref026","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.radonc.2021.07.012","article-title":"Outcomes of and treatment planning considerations for a hybrid technique delivering proton pencil-beam scanning radiation to women with metal-containing tissue expanders undergoing post-mastectomy radiation","volume":"164","author":"CM DeCesaris","year":"2021","journal-title":"Radiother Oncol"},{"issue":"11","key":"pone.0344699.ref027","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"SC Darby","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0344699.ref028","first-page":"4577","article-title":"Thyroid Function after Postoperative Radiation Therapy in Patients with Breast Cancer","volume":"17","author":"E Wolny-Rokicka","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"pone.0344699.ref029","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2022.04.052","article-title":"Radiation-Induced Hypothyroidism in Patients With Breast Cancer After Hypofractionated Radiation Therapy: A Prospective Cohort Study","volume":"115","author":"X-R Zhao","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"pone.0344699.ref030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0360-3016(91)90782-Y","article-title":"Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy","volume":"21","author":"TI Lingos","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"pone.0344699.ref031","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2017.06.006","article-title":"Postmastectomy radiation therapy technique and cardiopulmonary sparing: A dosimetric comparative analysis between photons and protons with free breathing versus deep inspiration breath hold","volume":"7","author":"SA Patel","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"pone.0344699.ref032","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2021.05.110","article-title":"Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee","volume":"111","author":"RW Mutter","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"pone.0344699.ref033","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ijrobp.2008.02.040","article-title":"Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study","volume":"72","author":"M Stovall","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"pone.0344699.ref034","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.radonc.2020.05.035","article-title":"The risk for developing a secondary cancer after breast radiation therapy: Comparison of photon and proton techniques","volume":"149","author":"H Paganetti","year":"2020","journal-title":"Radiother Oncol"},{"issue":"5","key":"pone.0344699.ref035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.clon.2019.12.005","article-title":"Estimating Contralateral Breast Cancer Risk from Photons versus Protons in Patients Undergoing Internal Mammary Nodal Breast Cancer Radiotherapy","volume":"32","author":"S Settatree","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"10","key":"pone.0344699.ref036","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.3390\/biomedicines10102568","article-title":"Ultra-Hypofractionation for Whole-Breast Irradiation in Early Breast Cancer: Interim Analysis of a Prospective Study","volume":"10","author":"V Sigaudi","year":"2022","journal-title":"Biomedicines"},{"issue":"13","key":"pone.0344699.ref037","article-title":"Ultrahypofractionation in postoperative radiotherapy for breast cancer: A single-institution retrospective cohort series","volume":"13","author":"A Calvo Tudela","year":"2024","journal-title":"Cancer Med"},{"key":"pone.0344699.ref038","first-page":"100764","article-title":"Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results","volume":"46","author":"I Ratosa","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"pone.0344699.ref039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2022.07.755","article-title":"Ultrahypofractionated adjuvant proton therapy for localized stage breast cancer: early toxicity report","volume":"114","author":"N Vorobyov","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"pone.0344699.ref040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrc2587","article-title":"Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype","volume":"9","author":"GC Barnett","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"pone.0344699.ref041","doi-asserted-by":"crossref","DOI":"10.1101\/2025.03.14.25323946","article-title":"Acute skin toxicity and cosmesis outcome in non-metastatic breast cancer patients treated with ultrahypofractionated radiotherapy: a randomized controlled phase II clinical trial comparing proton versus photon radiotherapy","author":"T Sarsitthithum","year":"2025"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:36:59Z","timestamp":1773250619000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344699"}},"subtitle":[],"editor":[{"given":"Gayle E.","family":"Woloschak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0344699","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}